Cargando…
Total Knee Replacement Delayed With Hylan G-F 20 Use in Patients With Grade IV Osteoarthritis
BACKGROUND: Total knee replacement (TKR), a last resort for treating knee pain due to osteoarthritis (OA), is not always medically indicated or preferred by many patients. Hylan G-F 20 is a cross-linked hyaluronan derivative approved for the treatment of pain due to OA of the knee after other conser...
Autores principales: | Waddell, David D., Bricker, DeWayne C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437553/ https://www.ncbi.nlm.nih.gov/pubmed/17330972 http://dx.doi.org/10.18553/jmcp.2007.13.2.113 |
Ejemplares similares
-
Viscosupplementation for knee osteoarthritis: a focus on Hylan G-F 20
por: Webb, David, et al.
Publicado: (2018) -
IMPROVEMENTS IN HIP OSTEOARTHRITIS WITH LAVAGE, TRIAMCINOLONE AND HYLAN G-F20
por: REZENDE, MÁRCIA UCHÔA DE, et al.
Publicado: (2020) -
Cost-effectiveness and budget impact analysis of viscosupplementation with hylan G-F 20 for knee and hip osteoarthritis
por: Migliore, Alberto, et al.
Publicado: (2019) -
Weekly injections of Hylan G-F 20 delay cartilage degeneration in partial meniscectomized rat knees
por: Yanagisawa, Katsuaki, et al.
Publicado: (2016) -
Managing joint pain in osteoarthritis: safety and efficacy of hylan G-F 20
por: Conduah, Augustine H, et al.
Publicado: (2009)